Key Takeaways for Synopsys Stock as of July 2026
- Model Upside: TIKR’s valuation model puts a $681 target on Synopsys stock, implying 82% total return and 15% annualized by October 2030.
- Analyst Split: Wall Street carries 14 buys, 4 outperforms, 5 holds, 1 no opinion and 1 underperform on Synopsys stock as of July 24, with zero sells and a mean target of $564.
- Royalty Pivot: Synopsys is converting its interface IP business from a flat use-fee model to use fee plus royalty on custom chips hyperscalers design in-house, what CEO Sassine Ghazi calls COT, a shift he says could meaningfully lift the growth rate of a business that just bottomed in fiscal Q1.
- Drawdown Depth: Synopsys stock has fallen 42% from its peak as of July 24, 2026, even as the IP business delivered the sequential rebound management promised.
Synopsys Stock’s IP Business Is Getting a Royalty Upgrade Hyperscalers Can’t Avoid
Synopsys (SNPS) is rebuilding its interface IP business around a royalty model tied to the custom chips hyperscalers are now designing in-house, a shift CEO Sassine Ghazi laid out at the Mizuho Technology Conference on June 9, 2026. The IP segment bottomed in fiscal Q1 and delivered the sequential growth management promised in Q2, but the bigger change is structural: Synopsys is negotiating with hyperscalers to move beyond licensing fees and capture a percentage of the upside on every custom chip built with its technology.
Ghazi described two IP business models running in parallel. The first, what he called factory one, is the traditional build-once-sell-many-times licensing business that has driven mid-teens growth for years. The second, factory two, covers customized IP for hyperscalers building their own silicon, chips Ghazi refers to as COT, to control compute costs against merchant alternatives. That customization work cannot be licensed the old way because it happens before the underlying standard is even finalized. Ghazi was direct about why that matters: “This COT cannot happen without Synopsys IP.” He tied the statement to active negotiations already underway, not a future possibility. Synopsys management expects factory two royalty growth to exceed the mid-teens factory one baseline, with full financial detail coming at the company’s Investor Day on September 30, 2026.
That’s the development repricing Synopsys stock. A licensing business built on flat fees is turning into one with participation rights in the chips it enables, and the timing lines up with a wave of hyperscaler chip starts that Ghazi says has not yet slowed.
Evidence that the royalty shift is already reaching analyst models is building elsewhere on the income statement: the Street projects Synopsys’s EBITDA margins peaking at 48% in the January 2027 quarter, up from 42% in the most recent quarter, with bulls pointing to that peak as proof the Ansys synergy and IP royalty monetization plans are starting to flow through the numbers. Bears counter that EBITDA growth is still modeled to slow to single digits by mid-2027, the exact point where Street caution and TIKR’s more aggressive re-rating diverge.
Synopsys stock’s royalty transition could reshape IP growth. See how TIKR models the upside →
Synopsys Stock Sits Near a 42% Drawdown While Analysts Stay Bullish
Synopsys stock hit a maximum drawdown of 42% on July 24, 2026, its deepest pullback on the chart, and the stock closed that day at $373.
The drawdown widened even as management confirmed the IP business inflection was playing out on schedule, a gap between operational progress and share price that hasn’t closed yet.
Wall Street’s rating count leans firmly bullish. Of the 25 analysts covering Synopsys stock as of July 24, 2026, 14 rate it a buy and 4 rate it an outperform, against 5 holds, 1 no opinion and 1 underperform, with zero sells. The mean price target sits at $564, up from $446 six months earlier, and implies 51% upside from the current $373 close.
That target has climbed even as the stock fell, pushing the target-to-close ratio to 151%, the widest gap on the six-period table provided.
TIKR Values Synopsys Stock at $681, Pricing In the IP Royalty Ramp
TIKR’s mid-case model values Synopsys stock at $681 by October 2030, implying 82% total return from the current price of $373, or 15% annualized over 4.3 years.
That annualized rate sits well above what investors typically demand from a mature enterprise software franchise, reflecting a business TIKR’s model treats as still in an earlier growth phase than its current multiple suggests. The gap between the 42% drawdown and the model’s 82.3% return case is the clearest read on how far sentiment has diverged from fundamentals.
The target rests on the IP business executing the shift Ghazi described: converting factory two customization work into royalty-bearing revenue as hyperscaler chip starts continue. If that royalty layer scales the way management outlined, the segment’s growth rate moves past the mid-teens factory one baseline, and that’s the exact mechanism the current stock price has not yet credited.
Should You Invest in Synopsys, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Synopsys, Inc. stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Synopsys, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze SNPS stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
